Mark L. Berch

Array ( [id] => 6543272 [patent_doc_number] => 20100125059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => '1-BIARYLAZETIDINONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/527013 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35545 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125059.pdf [firstpage_image] =>[orig_patent_app_number] => 12527013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725558 [patent_doc_number] => 08404674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/595072 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12526 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765849 [patent_doc_number] => 20080177061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Target for therapy of cognitive impairment' [patent_app_type] => utility [patent_app_number] => 12/074550 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34189 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177061.pdf [firstpage_image] =>[orig_patent_app_number] => 12074550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454447 [patent_doc_number] => 20100105652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PURINES AS CYSTEINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/529543 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30424 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105652.pdf [firstpage_image] =>[orig_patent_app_number] => 12529543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515703 [patent_doc_number] => 20090216010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'CRYSTALLINE CARBAPENEM COMPOUND AND PRODUCED METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/035489 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2355 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216010.pdf [firstpage_image] =>[orig_patent_app_number] => 12035489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685342 [patent_doc_number] => 20100120799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PURINE DERIVATIVES AS IMMUNOMODULATORS' [patent_app_type] => utility [patent_app_number] => 12/527820 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 89829 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120799.pdf [firstpage_image] =>[orig_patent_app_number] => 12527820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599810 [patent_doc_number] => 07977344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/031764 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 90442 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977344.pdf [firstpage_image] =>[orig_patent_app_number] => 12031764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860410 [patent_doc_number] => 20080269260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/031135 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19367 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269260.pdf [firstpage_image] =>[orig_patent_app_number] => 12031135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786254 [patent_doc_number] => 20080139583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/026198 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26009 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139583.pdf [firstpage_image] =>[orig_patent_app_number] => 12026198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5930291 [patent_doc_number] => 20110040086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Novel Beta-Lactam Antibiotics, Methods for Their Production, and Their Use' [patent_app_type] => utility [patent_app_number] => 12/525322 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14810 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20110040086.pdf [firstpage_image] =>[orig_patent_app_number] => 12525322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6607993 [patent_doc_number] => 20100063273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'NOVEL CRYSTAL OF PIPERACILLIN SODIUM' [patent_app_type] => utility [patent_app_number] => 12/524875 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6270 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063273.pdf [firstpage_image] =>[orig_patent_app_number] => 12524875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536273 [patent_doc_number] => 20100204187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Purine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/524234 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34675 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204187.pdf [firstpage_image] =>[orig_patent_app_number] => 12524234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465704 [patent_doc_number] => 20090325904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'MALEIC ACID MONOSALT OF ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/522046 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4435 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325904.pdf [firstpage_image] =>[orig_patent_app_number] => 12522046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873936 [patent_doc_number] => 20080200670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'METHOD FOR THE MANUFACTURE OF CEFTRIAXONE SODIUM' [patent_app_type] => utility [patent_app_number] => 12/013187 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15535 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200670.pdf [firstpage_image] =>[orig_patent_app_number] => 12013187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813962 [patent_doc_number] => 20080194593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'A2B ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/013348 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36205 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194593.pdf [firstpage_image] =>[orig_patent_app_number] => 12013348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765601 [patent_doc_number] => 20080176813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'CARBOCYCLIC NUCLEOSIDES AND PROCESS FOR OBTAINING SUCH' [patent_app_type] => utility [patent_app_number] => 11/970950 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13885 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176813.pdf [firstpage_image] =>[orig_patent_app_number] => 11970950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436292 [patent_doc_number] => 20090170879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => '6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions' [patent_app_type] => utility [patent_app_number] => 11/966559 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17554 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170879.pdf [firstpage_image] =>[orig_patent_app_number] => 11966559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527469 [patent_doc_number] => 08044061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => '8-alkynylxanthines and derivatives' [patent_app_type] => utility [patent_app_number] => 11/963477 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 45418 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044061.pdf [firstpage_image] =>[orig_patent_app_number] => 11963477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724452 [patent_doc_number] => 08097723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Process for the preparation of abacavir' [patent_app_type] => utility [patent_app_number] => 12/520510 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3084 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097723.pdf [firstpage_image] =>[orig_patent_app_number] => 12520510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92293 [patent_doc_number] => 07732455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Substituted 8-heteroaryl xanthines' [patent_app_type] => utility [patent_app_number] => 11/956876 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24059 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732455.pdf [firstpage_image] =>[orig_patent_app_number] => 11956876 [rel_patent_id] =>[rel_patent_doc_number] =>)